Acasti announces definitive agreement to acquire grace therapeutics, inc.

Grace provides acasti with a pipeline of rare and orphan disease programs, including 3 clinical stage assets that have received orphan drug designation from the fda
ACST Ratings Summary
ACST Quant Ranking